SUN PHARM FDA Approval ANDA 213725

ANDA 213725

SUN PHARM

FDA Drug Application

Application #213725

Documents

Letter2020-08-24

Application Sponsors

ANDA 213725SUN PHARM

Marketing Status

Prescription001

Application Products

001FOR SUSPENSION, DELAYED RELEASE;ORALEQ 40MG BASE0PANTOPRAZOLE SODIUMPANTOPRAZOLE SODIUM

FDA Submissions

UNKNOWN; ORIG1AP2020-06-30STANDARD
LABELING; LabelingSUPPL4AP2022-09-27STANDARD

Submissions Property Types

ORIG1Null7
SUPPL4Null7

TE Codes

001PrescriptionAB

CDER Filings

SUN PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213725
            [companyName] => SUN PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"PANTOPRAZOLE SODIUM","activeIngredients":"PANTOPRAZOLE SODIUM","strength":"EQ 40MG BASE","dosageForm":"FOR SUSPENSION, DELAYED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"06\/30\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-06-30
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.